AAAAAA

   
Results: 1-11 |
Results: 11
Outcome of fetuses with increased nuchal translucency
Authors: Bilardo, CM Muller, MA Pajkrt, E
Citation: Cm. Bilardo et al., Outcome of fetuses with increased nuchal translucency, CUR OP OBST, 13(2), 2001, pp. 169-174
Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome
Authors: Bilardo, CM Muller, MA Zikulnig, L Schipper, M Hecher, K
Citation: Cm. Bilardo et al., Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome, ULTRASOUN O, 17(4), 2001, pp. 288-294
Increased nuchal translucency and normal karyotype: coping with uncertainty
Authors: Bilardo, CM
Citation: Cm. Bilardo, Increased nuchal translucency and normal karyotype: coping with uncertainty, ULTRASOUN O, 17(2), 2001, pp. 99-101
The influence of fetal position on nuchal translucency thickness
Authors: de Graaf, IM Muller, MA Van Zuylen-Vie, AA Bleker, OP Bilardo, CM
Citation: Im. De Graaf et al., The influence of fetal position on nuchal translucency thickness, ULTRASOUN O, 15(6), 2000, pp. 520-522
Intra- and interoperator repeatability of the nuchal translucency measurement
Authors: Pajkrt, E Mol, BWJ Boer, K Drogtrop, AP Bossuyt, PMM Bilardo, CM
Citation: E. Pajkrt et al., Intra- and interoperator repeatability of the nuchal translucency measurement, ULTRASOUN O, 15(4), 2000, pp. 297-301
Enlarged nuchal translucency and low serum protein concentrations as possible markers for Zellweger syndrome
Authors: de Graaf, IM Pajkrt, E Keessen, M Leschot, NJ Bilardo, CM
Citation: Im. De Graaf et al., Enlarged nuchal translucency and low serum protein concentrations as possible markers for Zellweger syndrome, ULTRASOUN O, 13(4), 1999, pp. 268-270
Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency
Authors: de Graaf, IM Pajkrt, E Bilardo, CM Leschot, NJ Cuckle, HS van Lith, JMM
Citation: Im. De Graaf et al., Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency, PRENAT DIAG, 19(5), 1999, pp. 458-462
First-trimester non-invasive prenatal diagnosis of triploidy
Authors: de Graaf, IM van Bezouw, SMCA Jakobs, ME Leschot, NJ Zondervan, HA Bilardo, CM Hoovers, JMN
Citation: Im. De Graaf et al., First-trimester non-invasive prenatal diagnosis of triploidy, PRENAT DIAG, 19(2), 1999, pp. 175-177
Pregnancy outcome and nuchal translucency measurements in fetuses with a normal karyotype
Authors: Pajkrt, E Mol, BWJ Bleker, OP Bilardo, CM
Citation: E. Pajkrt et al., Pregnancy outcome and nuchal translucency measurements in fetuses with a normal karyotype, PRENAT DIAG, 19(12), 1999, pp. 1104-1108
Antenatal betamethasone and fetoplacental blood flow
Authors: Wijnberger, LDE Bilardo, CM Hecher, K Stigter, RH Visser, GHA
Citation: Lde. Wijnberger et al., Antenatal betamethasone and fetoplacental blood flow, LANCET, 354(9174), 1999, pp. 256-256
Effect of study design on the association between nuchal translucency measurement and Down syndrome
Authors: Mol, BWJ Lijmer, JG van der Meulen, J Pajkrt, E Bilardo, CM Bossuyt, PMM
Citation: Bwj. Mol et al., Effect of study design on the association between nuchal translucency measurement and Down syndrome, OBSTET GYN, 94(5), 1999, pp. 864-869
Risultati: 1-11 |